AAPL350.72-2.06 (-0.58%) ▼|ABBV292.37-2.18 (-0.74%) ▼|ABT104.93-2.52 (-2.35%) ▼|ACN240.58-7.12 (-2.87%) ▼|ADBE235.81-10.19 (-4.14%) ▼|AMAT343.11-7.14 (-2.04%) ▼|AMD489.57-14.71 (-2.92%) ▼|AMGN456.58-5.74 (-1.24%) ▼|AMT187.82-2.92 (-1.53%) ▼|AMZN257.34-0.41 (-0.16%) ▼|AVGO338.04+4.64 (+1.39%) ▲|AXP315.54-3.51 (-1.10%) ▼|BA163.68-1.54 (-0.93%) ▼|BAC49.43-0.66 (-1.31%) ▼|BKNG153.93-3.60 (-2.29%) ▼|BLK1,183.91-14.07 (-1.17%) ▼|BMY61.07-1.86 (-2.96%) ▼|BNY149.99-1.71 (-1.12%) ▼|BRK-B589.73-3.12 (-0.53%) ▼|C119.79-1.54 (-1.27%) ▼|CAT567.33-3.16 (-0.55%) ▼|CL99.60-1.39 (-1.38%) ▼|CMCSA25.48-0.13 (-0.49%) ▼|COF186.77-6.45 (-3.34%) ▼|COP139.57-0.95 (-0.68%) ▼|COST1,112.01-1.74 (-0.16%) ▼|CRM195.10-19.74 (-9.19%) ▼|CSCO94.64+0.12 (+0.12%) ▲|CVS85.64-2.95 (-3.33%) ▼|CVX215.75-1.39 (-0.64%) ▼|DE647.43-6.56 (-1.00%) ▼|DHR225.63-4.29 (-1.86%) ▼|DIS116.24-2.47 (-2.08%) ▼|DUK130.11-0.48 (-0.37%) ▼|EMR158.61-2.04 (-1.27%) ▼|FDX319.54-8.11 (-2.48%) ▼|GD355.04-4.65 (-1.29%) ▼|GE325.23+0.05 (+0.02%) ▲|GEV766.52+2.95 (+0.39%) ▲|GILD169.69+2.11 (+1.26%) ▲|GM83.62+0.01 (+0.01%) ▲|GOOG277.21-4.06 (-1.44%) ▼|GOOGL279.93-3.79 (-1.34%) ▼|GS875.54-16.00 (-1.79%) ▼|HD339.24-8.27 (-2.38%) ▼|HON218.95+1.00 (+0.46%) ▲|IBM231.29-11.22 (-4.63%) ▼|INTC53.74-1.71 (-3.08%) ▼|INTU322.33-23.23 (-6.72%) ▼|ISRG431.46-6.29 (-1.44%) ▼|JNJ279.09-3.47 (-1.23%) ▼|JPM329.90-8.31 (-2.46%) ▼|KO99.08-0.41 (-0.41%) ▼|LIN518.20-5.26 (-1.00%) ▼|LLY1,407.20-24.47 (-1.71%) ▼|LMT586.72+1.51 (+0.26%) ▲|LOW221.24-3.70 (-1.64%) ▼|LRCX207.04-3.79 (-1.80%) ▼|MA647.80-13.91 (-2.10%) ▼|MCD275.73+1.06 (+0.39%) ▲|MDLZ66.95-0.60 (-0.88%) ▼|MDT102.59-0.29 (-0.28%) ▼|META620.98-5.43 (-0.87%) ▼|MMM180.22-1.47 (-0.81%) ▼|MO77.88-1.02 (-1.29%) ▼|MRK143.62-0.85 (-0.58%) ▼|MS183.43-2.14 (-1.15%) ▼|MSFT505.48-12.51 (-2.42%) ▼|MU697.98-21.05 (-2.93%) ▼|NEE84.73-0.61 (-0.71%) ▼|NFLX59.60-1.15 (-1.89%) ▼|NKE35.45-2.81 (-7.34%) ▼|NOW92.43-6.94 (-6.98%) ▼|NVDA153.50-2.64 (-1.69%) ▼|ORCL114.66-4.43 (-3.72%) ▼|PEP141.79-4.65 (-3.17%) ▼|PFE28.43-0.43 (-1.49%) ▼|PG171.93-1.09 (-0.63%) ▼|PLTR156.68-3.72 (-2.32%) ▼|PM195.54-0.50 (-0.26%) ▼|QCOM165.37-3.15 (-1.87%) ▼|RTX197.23+2.34 (+1.20%) ▲|SBUX107.41-1.32 (-1.21%) ▼|SCHW91.97-0.98 (-1.05%) ▼|SO93.53-1.11 (-1.17%) ▼|SPG230.82-1.96 (-0.84%) ▼|T22.39+0.03 (+0.13%) ▲|TMO687.97-3.36 (-0.49%) ▼|TMUS169.02-0.99 (-0.58%) ▼|TSLA378.58-1.16 (-0.31%) ▼|TXN293.25-0.96 (-0.33%) ▼|UBER69.02-0.98 (-1.39%) ▼|UNH387.92-24.10 (-5.85%) ▼|UNP298.58-5.13 (-1.69%) ▼|UPS110.61-1.21 (-1.08%) ▼|USB59.33-1.10 (-1.82%) ▼|V418.16-8.30 (-1.95%) ▼|VZ46.18-0.17 (-0.36%) ▼|WFC82.87-1.97 (-2.32%) ▼|WMT127.50-0.91 (-0.71%) ▼|XOM166.68-0.19 (-0.11%) ▼|AAPL350.72-2.06 (-0.58%) ▼|ABBV292.37-2.18 (-0.74%) ▼|ABT104.93-2.52 (-2.35%) ▼|ACN240.58-7.12 (-2.87%) ▼|ADBE235.81-10.19 (-4.14%) ▼|AMAT343.11-7.14 (-2.04%) ▼|AMD489.57-14.71 (-2.92%) ▼|AMGN456.58-5.74 (-1.24%) ▼|AMT187.82-2.92 (-1.53%) ▼|AMZN257.34-0.41 (-0.16%) ▼|AVGO338.04+4.64 (+1.39%) ▲|AXP315.54-3.51 (-1.10%) ▼|BA163.68-1.54 (-0.93%) ▼|BAC49.43-0.66 (-1.31%) ▼|BKNG153.93-3.60 (-2.29%) ▼|BLK1,183.91-14.07 (-1.17%) ▼|BMY61.07-1.86 (-2.96%) ▼|BNY149.99-1.71 (-1.12%) ▼|BRK-B589.73-3.12 (-0.53%) ▼|C119.79-1.54 (-1.27%) ▼|CAT567.33-3.16 (-0.55%) ▼|CL99.60-1.39 (-1.38%) ▼|CMCSA25.48-0.13 (-0.49%) ▼|COF186.77-6.45 (-3.34%) ▼|COP139.57-0.95 (-0.68%) ▼|COST1,112.01-1.74 (-0.16%) ▼|CRM195.10-19.74 (-9.19%) ▼|CSCO94.64+0.12 (+0.12%) ▲|CVS85.64-2.95 (-3.33%) ▼|CVX215.75-1.39 (-0.64%) ▼|DE647.43-6.56 (-1.00%) ▼|DHR225.63-4.29 (-1.86%) ▼|DIS116.24-2.47 (-2.08%) ▼|DUK130.11-0.48 (-0.37%) ▼|EMR158.61-2.04 (-1.27%) ▼|FDX319.54-8.11 (-2.48%) ▼|GD355.04-4.65 (-1.29%) ▼|GE325.23+0.05 (+0.02%) ▲|GEV766.52+2.95 (+0.39%) ▲|GILD169.69+2.11 (+1.26%) ▲|GM83.62+0.01 (+0.01%) ▲|GOOG277.21-4.06 (-1.44%) ▼|GOOGL279.93-3.79 (-1.34%) ▼|GS875.54-16.00 (-1.79%) ▼|HD339.24-8.27 (-2.38%) ▼|HON218.95+1.00 (+0.46%) ▲|IBM231.29-11.22 (-4.63%) ▼|INTC53.74-1.71 (-3.08%) ▼|INTU322.33-23.23 (-6.72%) ▼|ISRG431.46-6.29 (-1.44%) ▼|JNJ279.09-3.47 (-1.23%) ▼|JPM329.90-8.31 (-2.46%) ▼|KO99.08-0.41 (-0.41%) ▼|LIN518.20-5.26 (-1.00%) ▼|LLY1,407.20-24.47 (-1.71%) ▼|LMT586.72+1.51 (+0.26%) ▲|LOW221.24-3.70 (-1.64%) ▼|LRCX207.04-3.79 (-1.80%) ▼|MA647.80-13.91 (-2.10%) ▼|MCD275.73+1.06 (+0.39%) ▲|MDLZ66.95-0.60 (-0.88%) ▼|MDT102.59-0.29 (-0.28%) ▼|META620.98-5.43 (-0.87%) ▼|MMM180.22-1.47 (-0.81%) ▼|MO77.88-1.02 (-1.29%) ▼|MRK143.62-0.85 (-0.58%) ▼|MS183.43-2.14 (-1.15%) ▼|MSFT505.48-12.51 (-2.42%) ▼|MU697.98-21.05 (-2.93%) ▼|NEE84.73-0.61 (-0.71%) ▼|NFLX59.60-1.15 (-1.89%) ▼|NKE35.45-2.81 (-7.34%) ▼|NOW92.43-6.94 (-6.98%) ▼|NVDA153.50-2.64 (-1.69%) ▼|ORCL114.66-4.43 (-3.72%) ▼|PEP141.79-4.65 (-3.17%) ▼|PFE28.43-0.43 (-1.49%) ▼|PG171.93-1.09 (-0.63%) ▼|PLTR156.68-3.72 (-2.32%) ▼|PM195.54-0.50 (-0.26%) ▼|QCOM165.37-3.15 (-1.87%) ▼|RTX197.23+2.34 (+1.20%) ▲|SBUX107.41-1.32 (-1.21%) ▼|SCHW91.97-0.98 (-1.05%) ▼|SO93.53-1.11 (-1.17%) ▼|SPG230.82-1.96 (-0.84%) ▼|T22.39+0.03 (+0.13%) ▲|TMO687.97-3.36 (-0.49%) ▼|TMUS169.02-0.99 (-0.58%) ▼|TSLA378.58-1.16 (-0.31%) ▼|TXN293.25-0.96 (-0.33%) ▼|UBER69.02-0.98 (-1.39%) ▼|UNH387.92-24.10 (-5.85%) ▼|UNP298.58-5.13 (-1.69%) ▼|UPS110.61-1.21 (-1.08%) ▼|USB59.33-1.10 (-1.82%) ▼|V418.16-8.30 (-1.95%) ▼|VZ46.18-0.17 (-0.36%) ▼|WFC82.87-1.97 (-2.32%) ▼|WMT127.50-0.91 (-0.71%) ▼|XOM166.68-0.19 (-0.11%) ▼|
13.7 C
New York
Tuesday, November 17, 2026

Tag: release

Inception Growth Acquisition Limited Announces Postponement of the Special Meeting to July 25, 2025 and Extension of Redemption Request Deadline

New York, July 10, 2025 (GLOBE NEWSWIRE) -- Inception Growth Acquisition Limited (the “Company”), a blank check company, today announced that its previously announced special meeting of shareholders (the “Special Meeting”) will be postponed from 10:00 a.m. Hong Kong Time on July 14, 2025 to 10:00 a.m. Hong Kong Time on July 25, 2025 and accordingly, the deadline for stockholders to submit redemption requests will be extended to July 23, 2025.

Hubbell to Announce Second Quarter 2025 Results on July 29, 2025

Shelton, CT, July 10, 2025 (GLOBE NEWSWIRE) -- Hubbell Incorporated (NYSE: HUBB) today announced it will release its second quarter 2025 financial results prior to the opening of the market on July 29th, 2025. The Company will then webcast its Analysts' Conference Call to discuss the results at 10:00 AM ET. 

NKGen Biotech Administers First Dose of Troculeucel to Alzheimer’s Patient Who Continued to Decline Cognitively While on Prior Amyloid-Targeting Therapy

SANTA ANA, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer (“NK”) cell therapeutics, today announced the administration of the first dose of troculeucel, an expanded autologous NK cell therapy, under a single compassionate use, Investigational New Drug (“IND”) authorization cleared by the U.S. Food and Drug Administration (“FDA”), to a patient with mild-stage Alzheimer’s disease who exhibited continued cognitive decline despite ongoing treatment with lecanemab, an amyloid targeting therapy. This exploratory work is being conducted in collaboration with Anita Fletcher, M.D., a board-certified neurologist with specialized training in neuroimmunology, who also serves as Director of Neuroscience Clinical Research at AdventHealth Neuroscience Institute in Orlando, Florida.

Clearway Energy, Inc. to Report Second Quarter 2025 Financial Results on August 5, 2025

PRINCETON, N.J., July 10, 2025 (GLOBE NEWSWIRE) -- Clearway Energy, Inc. (NYSE: CWEN, CWEN.A) plans to report Second Quarter 2025 financial results on Tuesday, August 5, 2025. Management will present the results during a conference call and webcast at 5:00 p.m. Eastern.

The Wendy’s Company to Report Second Quarter 2025 Results on August 8

DUBLIN, Ohio, July 10, 2025 /PRNewswire/ -- The Wendy's Company (Nasdaq: WEN) will release its second quarter 2025 results before the market opens on...

Clorox Announces July 31 Webcast of Fourth-Quarter and Fiscal Year 2025 Results

OAKLAND, Calif., July 10, 2025 /PRNewswire/ -- The Clorox Company (NYSE: CLX) will issue its fourth-quarter and fiscal year 2025 results on July 31,...

Crinetics Pharmaceuticals Announces July 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, July 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on July 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 102,350 shares of its common stock and granted an aggregate of 77,875 restricted stock unit (“RSU”) awards to 46 new non-executive employees, in each case, under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options and RSUs were granted as inducements material to the employees entering into employment with Crinetics in accordance with Nasdaq Listing Rule 5635(c)(4).

VEON and Cohen Circle Secure Investor Commitments for Kyivstar Listing

Kyiv, New York, Dubai, and Philadelphia – July 10, 2025 – VEON Ltd. (Nasdaq: VEON) (“VEON”), a global digital operator, and Cohen Circle Acquisition Corp. I (“Cohen Circle”), a special purpose acquisition company (Nasdaq: CCIR), today announce the execution of non-redemption agreements (“NRAs”) totaling approximately USD 52.3 million with accredited institutional investors, including Helikon and Clearline. These commitments cover approximately 5.05 million CCIR Class A shares, securing the minimum USD 50 million cash condition for the proposed business combination of Kyivstar Group Ltd (“Kyivstar Group”) and Cohen Circle (the “Business Combination”).

Elme Communities to Release Second Quarter 2025 Results on Tuesday, August 5th

BETHESDA, Md., July 10, 2025 (GLOBE NEWSWIRE) -- Elme Communities (the “Company” or “Elme”) (NYSE:ELME), a value-oriented multifamily owner and operator, will release second quarter earnings results after market close on Tuesday, August 5, 2025. A conference call to discuss these results will be conducted on Wednesday, August 6, 2025, at 10:00 am ET. Conference call and webcast access information is as follows:

Genpact Limited Board Declares Quarterly Cash Dividend

NEW YORK, July 10, 2025 /PRNewswire/ -- Genpact Limited (NYSE: G), a global advanced technology services and solutions company, today announced that its board...

Serina Therapeutics Makes Grant to New Employee Under Inducement Plan

HUNTSVILLE, AL, July 10, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company advancing its lead IND candidate SER-252 for advanced Parkinson's disease, enabled by its proprietary POZ Platform™ drug optimization technology, announced that it has made a grant of options to purchase an aggregate of 12,500 shares of Serina’s common stock to a new non-executive employee on June 18, 2025 (the “Option Grant”).

Coca-Cola Consolidated, Inc. To Release Second Quarter and First Half 2025 Results

CHARLOTTE, N.C., July 10, 2025 (GLOBE NEWSWIRE) -- Coca-Cola Consolidated, Inc. (NASDAQ: COKE) will issue a news release after the market closes on July 24, 2025 to announce its operating results for the second quarter ended June 27, 2025 and the first half of fiscal 2025.

Gevo’s RNG Subsidiary Closes $40 Million in New Bond Sales, Refinances Debt, and Strengthens Gevo Balance Sheet

ENGLEWOOD, Colo., July 10, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) is pleased to announce that Barclays Capital Inc. has purchased $40 million of newly issued non-recourse tax-exempt private activity bonds (the “2025 Bonds”) issued by the Iowa Finance Authority for the benefit of Gevo’s wholly owned subsidiary, Gevo NW Iowa RNG, LLC (“Gevo RNG”). The bond proceeds were used to refinance $40 million of the previously issued Iowa Finance Authority Solid Waste Facility Revenue Bonds (Gevo NW Iowa RNG, LLC Renewable Natural Gas Project), Series 2021 (Green Bonds) (the “Previous Bonds”), which were issued in the aggregate principal amount of $68.2 million and secured by an irrevocable direct pay letter of credit. This partial refinancing of the Previous Bonds enabled Gevo to release $40 million of restricted cash that was securing the letter of credit and increase its balance sheet liquidity by approximately $30 million after paying transaction costs and funding reserves associated with the 2025 Bonds.

Maze Therapeutics to Participate in Two Upcoming Investor Conferences

Maze Therapeutics to Participate in Two Upcoming Investor Conferences

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRelease